NASDAQ:INSY - Nasdaq -
The FDA has accepted Insys Therapeutics' (NASDAQ:INSY) NDA for its investigational, naloxone nasal spray for the emergency treatment of opioid overdose in both adult and pediatric patients.A single u
Five states have agreed to facilitate settlement talks by dropping objections to a bid by Insys Therapeutics (NASDAQ:INSY) in bankruptcy court to put on hold their lawsuits alleging the drugmaker help
Indica and sativa are commonly-known distinctions among cannabis enthusiasts. But is there actually a distinct difference between the two? What roles do cannabinoids and terpenes play?
Insys Therapeutics, Inc. (NASDAQ: INSY) shares are trading sharply lower following news the company initiated a court supervised process to facilitate asset sales via Chapter 11...
VSTM – VSTM leads the way today as the best performing small cap stock, closing up 25.00%.
BXG – BXG leads the way today as the best performing small cap stock, closing up 31.13%.
Insys Therapeutics Inc (NASDAQ: INSY) Chairman Steven Meyer and board member Pierre Lapalme will resign "upon the execution of the agreements relating to the settlement with...
ADOM – ADOM leads the way today as the best performing small cap stock, closing up 42.86%.
Insys Therapeutics bankruptcy news for Wednesday has INSY stock heading higher on approval for the company's First Day motions,
The Insys Therapeutics bankruptcy news coming out on Monday about it filing for Chapter 11 has INSY stock tanking hard today.
INSYS Therapeutics (NASDAQ:INSY) -63% on filing Chapter 11 for bankruptcy.Spark Therapeutics (NASDAQ:ONCE) -12% after delayed takeover by Roche.Genocea Biosciences (NASDAQ:GNCA) -8%.Novavax (NASDAQ:NV
Insys says it will continue to operate its business 'in the ordinary course' while it sells off its assets through bankruptcy court.
Buckling under the weight of opioid lawsuits, INSYS Therapeutics (NASDAQ:INSY) has filed for Chapter 11 bankruptcy and will sell substantially all of its assets.The Company intends to continue operat
Drugmaker Insys Therapeutics Inc., whose former executives were convicted of bribing doctors to prescribe its highly addictive opioid, filed for bankruptcy protection after agreeing to pay hundreds of millions of dollars to settle a probe by U.S. prosecutors.
Insys Therapeutics (NASDAQ:INSY) has been halted for volatility after an 81% jump. The stock had declined postmarket last night (before turning up on a few small trades) in the aftermath of a governm
Insys Therapeutics (NASDAQ:INSY) will pay $225M and one of its units will plead guilty to mail fraud in a settlement with the government of criminal and civil charges. Shares are down 6% after hours.
Insys Therapeutics Inc. agreed to pay $225 million to resolve the government’s civil and criminal investigations into illegal sales of its opioid-based painkiller as the drugmaker grapples with the prospect of bankruptcy.
It's not a great reason in and of itself to buy Canopy Growth stock, but it does have an overlooked presence in the medical cannabis arena.
High short interest in a stock could be a buy signal. The short selling indicates short sellers who will eventually need to buy the stock.